Allergan
Allergan plc is a global pharmaceutical company specializing in aesthetics, eye care, neurosciences, and gastrointestinal treatments.

Overview[edit]
Founded as a small eye care company, Allergan has since grown into a multifaceted pharmaceutical giant, known especially for its product Botox.
History[edit]
- 1948: Allergan was founded by Gavin S. Herbert to produce nose drops and an anti-allergy medication in Los Angeles.
- 1950s: The company expanded into eye care products, launching its first blockbuster drug, an eye drop.
- 1980s-1990s: Allergan expanded globally, establishing its presence in over 100 countries.
- 2015: Allergan was acquired by Actavis plc, which then adopted the name Allergan.
- 2020: AbbVie acquired Allergan in a deal worth approximately $63 billion.
Notable Products[edit]
- Botox (onabotulinumtoxinA): A neurotoxin used for various cosmetic and therapeutic treatments.
- Restasis: A medication used to increase tear production in people with dry eyes.
- Juvederm: A range of injectable dermal fillers.
- CoolSculpting: A non-surgical body contouring treatment.
Research and Development[edit]
Allergan has been at the forefront of R&D in its specialized fields, with a focus on patient-centric innovation. Its R&D centers globally collaborate on drug discovery and development.
Corporate Social Responsibility[edit]
Allergan has committed itself to sustainability, patient welfare, and community service. Their initiatives include patient assistance programs, donations, and environmental sustainability practices.
Controversies[edit]
Allergan has faced its share of controversies, especially related to drug pricing, patents, and FDA regulations.
Facilities[edit]
With its global presence, Allergan has R&D, manufacturing, and commercial operations located in various regions around the world.
See Also[edit]
References[edit]
- [1] "Allergan: Our History". Allergan Official Website.
- [2] "The Evolution of Allergan". Pharmaceutical Executive Magazine.
- [3] "AbbVie Completes Acquisition of Allergan". Reuters.
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
Medical weight loss NYC | Affordable GLP-1 injections NYC | Budget GLP-1 weight loss shots Philadelphia | New Jersey medical weight loss | NYC medical weight loss | Philadelphia medical weight loss | Sleep clinic NYC | W8MD's Philadelphia GLP-1 doctor | Weight loss prescriptions NYC
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian